Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)

Xiaojun Yang

Status: Completed

Conditions: Patient-reported Outcomes

Study type: Observational

Funder types: Other

Identifiers

NCT03341377

SCCHEC-02-2017-042

Details and patient eligibility

About

Investigators propose a multicenter prospective observational cohort study to develop and validate essential technical parameters for establishing the patient-reported outcome-based perioperative symptom management cohort in patients with lung cancer. With at least 300 patients with initial diagnosis of lung cancer and scheduled for surgery, this study will administer symptom assessments (MDASI-LC) and quality of life assessments (SIQOL) before surgery (typically within 3 days before surgery), daily after surgery (in hospital ≤ 14 days), and weekly after discharge, up to 4 weeks (±3 days) or the start day of postoperative oncologic treatment. In the upgraded research protocol, symptom and quality of life assessments (every 3 month for 1 year, every 6 month for 2-3 year, every 12 month for 4-5 year), as well as the follow-up of clinical outcomes will continue until 5 years after surgery.

Enrollment: 512 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Be pathologically or clinically diagnosed as primary lung cancer before surgery;
2. Plan to undergo a surgical procedure.

Exclusion criteria

1. Aged younger than 18;
2. Diagnosis of cognitive impairment or unable to understand the study requirements.

Trial design

512 participants in 1 patient group

Lung cancer surgical patients

Description:

Patient-reported symptom assessments in patients undergoing lung cancer surgery.